NCT04356300View on ClinicalTrials.gov

Exosome of Mesenchymal Stem Cells for Multiple Organ Dysfuntion Syndrome After Surgical Repaire of Acute Type A Aortic Dissection

NANot yet recruitingINTERVENTIONAL

Enrollment

60

Participants

Timeline

Start Date

September 1, 2020

Primary Completion Date

September 1, 2021

Study Completion Date

September 1, 2030

Conditions

Multiple Organ Failure

Interventions

BIOLOGICAL

Exosome of MSC

Exosome of MSC at a dose of 150mg will be given intravenously to patients once a day for 14 times.

All Listed Sponsors

lead

Fujian Medical University

OTHER